Kaletra is a combination of two active ingredients Lopinavir / Ritonavir. It is indicated for the treatment of HIV infection and AIDS. This medicine is manufactured by AbbVie Inc., one of the top pharmaceutical companies. It is available in a conventional tablet form and in a dosage of 200 mg and 50 mg.
Manufacturer: AbbVie Inc.
Active Ingredient: This medicine is composed of a combination of two active ingredients Lopinavir and Ritonavir. Lopinavir is an antiretroviral protease inhibitor indicated in combination with ritonavir for the prevention of human immunodeficiency virus infection and the acquired immunodeficiency syndrome (AIDS). In HBV or HCV infected people highly active antiretroviral therapy with this medication is a result of an exacerbation of the underlying chronic hepatitis B or C.
Ritonavir component belongs to a class of drugs known as an antiretroviral protease inhibitor. This active component is a peptidomimetic agent that inhibits both HIV-1 and HIV-2 proteases and inhibited by serum proteins.
Indications: This mentioned a combination of ingredients used with other HIV medications to help control HIV infection. This drug helps decrease the amount of HIV in the body so that the immune system can work better. Kaletra lowers the risk of getting HIV complications like new infections, cancer and improves the quality of life. Active ingredients are HIV protease inhibitors.
Action Mechanism: This medication actively blocks the action of protease and leads to the formation of defective viruses that are unable to infect cells of the body. As a consequence, the number of viruses in the body reduces. Nevertheless, Kaletra does not prevent the transmission of HIV among individuals.
Dosages: Above HIV protease inhibitor drug is available in a dosage as mentioned below:
- 200 mg + 50 mg: It must be taken orally once a day with or without food as directed by the doctor
Note: This medication is not recommended to cure HIV or AIDS. It can only control the infection.